Since its enactment in 2022, the Chips and Science Act — a $280 billion splurge intended to revive US semiconductor manufacturing — has been at best a mixed success. A
Boosting domestic chipmaking is a reasonable goal. Although the US leads the world in chip design, it accounts for only about 10% of global production. That has left American companies — and, more pointedly, the Department of Defense — heavily reliant on overseas manufacturers, especially in Taiwan, ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.